Pregnancy News and Research

Latest Pregnancy News and Research

ICM provides formal endorsement of Direct Relief Midwife Kit as global standard for midwives

The International Confederation of Midwives has provided its first-ever formal endorsement of a Midwife Kit as a standard for midwives trained to ICM's competency standards. The Midwife Kit was developed by Direct Relief in consultation with ICM experts. Direct Relief will provide the kit free of charge to midwives in developing countries.

4 Jun 2015

TAPP awarded grant to support reproductive health care programs for pregnant teens in DC

Teenage girls in the District of Columbia's Anacostia neighborhood are twice more likely to become teen mothers than their peers in other parts of the city, and almost three times more likely than the national average.

4 Jun 2015

Maternal obesity increases health risks for mothers and their babies

Women with obesity have a range of increased health risks in pregnancy, both for them and their babies, compared with those in the healthy weight category, according to a new systematic review of research by academics at the School of Nursing and Midwifery, Trinity College Dublin, the University of Gothenberg, and City University London.

4 Jun 2015

Women & Infants Hospital awarded $5 million NIH grant to support COBRE for Perinatal Biology

Women & Infants Hospital of Rhode Island has recently received a nearly $5 million grant from the National Institutes of Health to support an Institutional Development Award Center of Biomedical Research Excellence for Perinatal Biology.

4 Jun 2015

Everyday Health, Wildflower Health partner to improve health outcomes in pregnant women

Everyday Health, Inc., a leading digital health and wellness company, today announced a strategic partnership with Wildflower Health. Through this partnership, Everyday Health expands its suite of offerings to help health plans and employers reach and engage pregnant women earlier in their pregnancies to improve health outcomes and reduce medical costs.

3 Jun 2015

New mobile app may help adolescents make more informed decisions about sexual behavior

Teenagers, parents, educators and clinicians will have a new tool to help adolescents make more informed decisions about their sexual behavior. "Seventeen Days," a mobile app based on the interactive movie of the same name, will be available at no cost on iPhone, iPad and Android devices beginning June 4.

3 Jun 2015

Use of antidepressants in late pregnancy may be associated with increased risk of PPHN

An analysis of approximately 3.8 million pregnancies finds that use of antidepressants late in pregnancy may be associated with an increased risk of persistent pulmonary hypertension of the newborn (PPHN), according to a study in the June 2 issue of JAMA. However, the absolute risk was small and the risk increase appears more modest than suggested in previous studies.

3 Jun 2015

University of Adelaide research shows genetics play vital role in the cause of cerebral palsy

University of Adelaide researchers have discovered cerebral palsy has an even stronger genetic cause than previously thought, leading them to call for an end to unnecessary caesareans and arbitrary litigation against obstetric staff.

3 Jun 2015

March of Dimes funds studies that explore factors, mechanisms involved in placental malaria

Malaria infection during pregnancy poses serious risks to women and infants. The March of Dimes Foundation, an American organization that works to improve pregnancy and baby health, has now funded Carlos Penha-Goncalves' laboratory, at the Instituto Gulbenkian de Ciencia (IGC, Portugal), for their studies on factors and mechanisms involved in placental malaria. This is the first time that this American Foundation funds research from a Portuguese Institution.

3 Jun 2015

Researchers explore association between SSRI exposure in late pregnancy and risk of PPHN

Use of antidepressants late in pregnancy has been controversial since the FDA issued a Public Health Advisory in 2006 warning that the use of antidepressants in late pregnancy may increase risk of persistent pulmonary hypertension of the newborn (PPHN), a condition that typically occurs in term or near-term infants and presents within hours of birth with severe respiratory failure requiring intubation and mechanical ventilation.

2 Jun 2015

Helsinn's Akynzeo for CINV prevention receives EC approval

Helsinn, the Swiss Group focused on building quality cancer care, announces today that on 27th May 2015, the European Commission (EC) approved Akynzeo® (netupitant-palonosetron) for the prevention of acute and delayed nausea and vomiting associated with highly emetogenic cisplatin-based cancer chemotherapy and moderately emetogenic cancer chemotherapy in the European Union.

2 Jun 2015

Telbivudine drug prevents perinatal transmission of HBV

The antiviral drug telbivudine prevents perinatal transmission of hepatitis B virus (HBV), according to a study in the June issue of Clinical Gastroenterology and Hepatology, the official clinical practice journal of the American Gastroenterological Association.

2 Jun 2015

Upsher-Smith announces FDA approval of sNDA for Qudexy XR extended-release capsules

Upsher-Smith Laboratories, Inc. announced that it has received U.S. Food and Drug Administration approval of a supplemental new drug application (sNDA) for Qudexy XR (topiramate) extended-release capsules for use as initial monotherapy in patients two years of age and older who are experiencing partial-onset seizures (POS) or primary generalized tonic-clonic seizures.

2 Jun 2015

Boehringer announces LUX-Lung 8 data that compares efficacy of afatinib, erlotinib in patients with advanced SCC

Boehringer Ingelheim today announced overall survival (OS) results from the LUX-Lung 8 trial (NCT01523587) that directly compared the efficacy and safety of two EGFR-directed treatments, afatinib and erlotinib, in patients with advanced squamous cell carcinoma (SCC) of the lung, progressing after treatment with first-line chemotherapy. Treatment with afatinib significantly reduced the risk of death by 19%, extending the survival of patients to a median of 7.9 months compared to 6.8 months on erlotinib.

1 Jun 2015

Pharmacyclics's Phase III RESONATE™ trial shows adherence to 420mg dose of IMBRUVICA improves outcomes in CLL patients

Pharmacyclics LLC today highlighted results from a sub-analysis of the Phase III RESONATE™ (PCYC-1112) trial, which found that previously-treated patients with chronic lymphocytic leukemia (CLL) who adhered to the recommended 420 mg dose of IMBRUVICA® (ibrutinib) experienced improved progression-free survival (PFS; the primary endpoint) as assessed by an Independent Review Committee (IRC), compared to patients who took lower doses or missed doses, regardless of high-risk genetic factors.

1 Jun 2015

Pharmacyclics’ Ibrutinib Phase Ib/II data show ibrutinib may be safe and effective in patients with cGVHD

Pharmacyclics LLC today announced interim results from the ongoing Phase Ib/II PCYC-1129 study suggesting that ibrutinib (IMBRUVICA) may be a safe and effective treatment for patients with chronic graft-versus-host-disease (cGVHD) who were either refractory to steroid treatment or were steroid-dependent.

1 Jun 2015

Alternative rehabilitation program for women diagnosed with diastasis recti

A series of online exercises and on demand curriculum is now available for women battling a not so well-known condition called diastasis recti. Founder, Raintree Sumazin, retired ballerina, pilates and yoga instructor, and certified holistic health counselor, brought this program to life after herself recovering from 8 finger diagnosis of the condition.

1 Jun 2015

Smartphone digital ruler ensures correctly-fitting condom

From now on, men around the world can make sure they get the right size condoms by measuring their penis with their smartphone. On the mobile website MeasureYourPenis.today, men can measure the girth of their penis by placing it on a digital ruler. Seven different colour codes representing different girths are used to provide advice and an additional explanation about condom sizes.

1 Jun 2015

Phase III HELIOS trial results show ibrutinib combination therapy improves outcomes in CLL/SLL patients

Today, Pharmacyclics LLC announced the results of the Phase III HELIOS trial (CLL3001), which found that patients with previously treated chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who received ibrutinib (IMBRUVICA) in combination with bendamustine and rituximab (BR) experienced an 80% reduction in the risk of progression or death compared to patients receiving placebo in combination with BR.

1 Jun 2015

Amgen and Merck expand collaboration for Talimogene laherparepvec-KEYTRUDA combination study

Amgen and Merck, known as MSD outside the U.S. and Canada, today announced an expanded collaboration to evaluate the efficacy and safety of talimogene laherparepvec, Amgen's investigational oncolytic immunotherapy, in combination with KEYTRUDA® (pembrolizumab), Merck's anti-PD-1 therapy, in a Phase 1, open-label trial of patients with recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN).

1 Jun 2015

Pregnancy News and Research

Latest Pregnancy News and Research

ICM provides formal endorsement of Direct Relief Midwife Kit as global standard for midwives

TAPP awarded grant to support reproductive health care programs for pregnant teens in DC

Maternal obesity increases health risks for mothers and their babies

Women & Infants Hospital awarded $5 million NIH grant to support COBRE for Perinatal Biology

Everyday Health, Wildflower Health partner to improve health outcomes in pregnant women

New mobile app may help adolescents make more informed decisions about sexual behavior

Use of antidepressants in late pregnancy may be associated with increased risk of PPHN

University of Adelaide research shows genetics play vital role in the cause of cerebral palsy

March of Dimes funds studies that explore factors, mechanisms involved in placental malaria

Researchers explore association between SSRI exposure in late pregnancy and risk of PPHN

Helsinn's Akynzeo for CINV prevention receives EC approval

Telbivudine drug prevents perinatal transmission of HBV

Upsher-Smith announces FDA approval of sNDA for Qudexy XR extended-release capsules

Boehringer announces LUX-Lung 8 data that compares efficacy of afatinib, erlotinib in patients with advanced SCC

Pharmacyclics's Phase III RESONATE™ trial shows adherence to 420mg dose of IMBRUVICA improves outcomes in CLL patients

Pharmacyclics’ Ibrutinib Phase Ib/II data show ibrutinib may be safe and effective in patients with cGVHD

Alternative rehabilitation program for women diagnosed with diastasis recti

Smartphone digital ruler ensures correctly-fitting condom

Phase III HELIOS trial results show ibrutinib combination therapy improves outcomes in CLL/SLL patients

Amgen and Merck expand collaboration for Talimogene laherparepvec-KEYTRUDA combination study

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Pregnancy News and Research

Latest Pregnancy News and Research

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Newsletters you may be interested in